Hubungan Indeks Massa Tubuh dengan Keparahan dan Kematian Pasien Covid-19 di RSU Haji Surabaya

Uswatun Hasanah

doi:10.22146/farmaseutik.v18i4.72748

Hubungan Indeks Massa Tubuh dengan Keparahan dan Kematian Pasien Covid-19 di RSU Haji Surabaya

https://doi.org/10.22146/farmaseutik.v18i4.72748

Uswatun Hasanah^(1*)

(1) Fakultas Farmasi, Universitas Ahmad
(*) Corresponding Author

Abstract

COVID-19 merupakan penyakit baru yang muncul dan dikenali pada Desember 2019. Penyakit ini menyebabkan kasus kematian yang masif di banyak negara di dunia, sehingga WHO dinyatakan sebagai pandemi global. Peningkatan kasus kematian akibat COVID-19 juga dirasakan di Indonesia. Hingga Februari 2022, jumlah kematian tercatat 3,30% lebih tinggi dari kasus kematian dunia sebesar 2,3% dan WHO 1,50%. Peningkatan indek massa tubuh dapat mempengaruhi kondisi klinis pasien, termasuk keparahan kasus hingga kematian pada pasien. Pasien dengan IMT yang meningkat dinyatakan sebagai faktor risiko keparahan dan kematian pasien COVID-19. Tujuan dari penelitian ini adalah untuk mengetahui hubungan IMT dengan tingkat keparahan dan mortalitas pasien COVID-19. Metode penelitian menggunakan kohort retrospektif yang dilakukan pada pasien rawat inap COVID-19 di RSU Haji Surabaya periode Maret 2020 hingga Maret 2021. Analisis data dalam menilai hubungan antar variabel uji dihitung menggunakan uji Chi-square dengan nilai signifikansi (p<0,05). Hasil penelitian yang dilakukan di RSU Haji Surabaya menunjukkan tidak terdapat hubungan antara indeks massa tubuh dengan tingkat keparahan kasus (p=0,065) dan terdapat hubungan yang signifikan antara IMT dengan mortalitas pasien (p=0,014). Kesimpulan penelitian diperoleh bahwa pasien COVID-19 denga IMT yang kurang atau berlebih dapat memungkinkan meningkatkan keparahan kasus dan mortalitas.

Keywords

COVID-19; IMT; mortalitas; keparahan

References

Adimara, A., Prahasanti, K., & Airlangga, M. P. (2021). Obesitas Mempengaruhi Tingkat Keparahan Pasien COVID-19. Online) Jurnal Ilmiah Kedokteran Wijaya Kusuma, 10(2), 222–242.

Aqmarina, N. W., Risanti, E. D., Mahmudah, L. N. ., & Jatmiko, S. W. (2021). Obesitas Sebagai Faktor Risiko Keparahan Pada Covid-19. Proceeding of The URECOL, November 2020, 371–377.

Arulanandam, B., Beladi, H., & Chakrabarti, A. (2021). COVID-19 mortality and the overweight: Cross-Country Evidence. Current Research in Food Science, 2(August), 100179. https://doi.org/10.1016/j.puhip.2021.100179

Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, E., Forma, A., Karakuła, K., Flieger, W., Portincasa, P., & Maciejewski, R. (2020). COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. Journal of Clinical Medicine, 9(6), 1753. https://doi.org/10.3390/jcm9061753

Dana, R., Bannay, A., Bourst, P., Ziegler, C., Losser, M. R., Gibot, S., Levy, B., Audibert, G., & Ziegler, O. (2021). Obesity and mortality in critically ill COVID-19 patients with respiratory failure. International Journal of Obesity, 45(9), 2028–2037. https://doi.org/10.1038/s41366-021-00872-9

Gao, M., Piernas, C., Astbury, N. M., Hippisley-Cox, J., O’Rahilly, S., Aveyard, P., & Jebb, S. A. (2021). Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. The Lancet Diabetes and Endocrinology, 9(6), 350–359. https://doi.org/10.1016/S2213-8587(21)00089-9

Kananen, L., Eriksdotter, M., Boström, A. M., Kivipelto, M., Annetorp, M., Metzner, C., Bäck Jerlardtz, V., Engström, M., Johnson, P., Lundberg, L. G., Åkesson, E., Sühl Öberg, C., Hägg, S., Religa, D., Jylhävä, J., & Cederholm, T. (2021). Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19. Clinical Nutrition, xxxx. https://doi.org/10.1016/j.clnu.2021.07.025

Kang, I. S., & Kong, K. A. (2021). Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea. PLOS ONE, 16(6), e0253640. https://doi.org/10.1371/journal.pone.0253640

Kemenkes, R. (2022). Situasi Covid-19. https://www.kemkes.go.id/

Kemenkes RI. (2019). Tabel Batas Ambang indeks Massa tubuh (IMT).

Kim, S. Y., Yoo, D., Min, C., Wee, J. H., Kim, J., & Choi, H. G. (2020). Analysis of Mortality and Morbidity in COVID-19 Patients with Obesity Using Clinical Epidemiological Data from the Korean Center for Disease Control & Prevention. International Journal of Environmental Research and Public Health, 17, 9336.

Kompaniyets, L., Goodman, A. B., Belay, B., Freedman, D. S., Sucosky, M. S., Lange, S. J., Gundlapalli, A. V., Boehmer, T. K., & Blanck, H. M. (2021). Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020. MMWR Surveillance Summaries, 70(10), 355–361. https://doi.org/10.15585/mmwr.mm7010e4

Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G., & Petersen, E. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . January.

Plourde, G., Fournier-Ross, E., Tessier-Grenier, H., Mullie, L. A., Chassé, M., & Carrier, F. M. (2021). Association between obesity and hospital mortality in critical COVID-19: a retrospective cohort study. International Journal of Obesity, August, 30–32. https://doi.org/10.1038/s41366-021-00938-8

Rahayu, L. A. D., Admiyanti, J. C., Khalda, Y. I., Ahda, F. R., Agistany, N. F. F., Setiawati, S., Shofiyanti, N. I., & Warnaini, C. (2021). Hipertensi, Diabetes Mellitus, Dan Obesitas Sebagai Faktor Komorbiditas Utama Terhadap Mortalitas Pasien Covid-19: Sebuah Studi Literatur. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(1), 90–97. https://doi.org/10.53366/jimki.v9i1.342

Sahin, S., Sezer, H., Cicek, E., Yaglz Ozogul, Y., Yildirim, M., Icli, T. B., Polat Korkmaz, O., Durcan, E., Sulu, C., Somay, K., Bekdemir, B., Borekci, S., Yazici, D., Deyneli, O., Ergonul, O., Tabak, F., Dikmen, Y., Ozkaya, H. M., Gonen, M. S., … Yumuk, V. D. (2021). The role of obesity in predicting the clinical outcomes of COVID-19. Obesity Facts, 14(5), 481–489. https://doi.org/10.1159/000517180

Sharma, J. R., & Yadav, U. C. S. (2021). COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Obesity Research and Clinical Practice, 15(2), 163–171. https://doi.org/10.1016/j.orcp.2021.01.004

Sorouri, M., Kasaeian, A., Mojtabavi, H., Radmard, A. R., Kolahdoozan, S., Anushiravani, A., Khosravi, B., Pourabbas, S. M., Eslahi, M., Sirusbakht, A., Khodabakhshi, M., Motamedi, F., Azizi, F., Ghanbari, R., Rajabi, Z., Sima, A. R., Rad, S., & Abdollahi, M. (2020). Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study. Infectious Agents and Cancer, 15(1), 1–11. https://doi.org/10.1186/s13027-020-00339-y

WHO. (2022). Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Wu, X., Li, C., Chen, S., Zhang, X., Wang, F., Shi, T., Li, Q., & Lin, L. (2021). Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China. Aging, 13(6), 7767–7780. https://doi.org/10.18632/aging.202813

Yuliana. (2020). Corona Virus Diseases (COVID-19) ; A literature review. Parque de Los Afectos. Jóvenes Que Cuentan, 2(February), 124–137. https://doi.org/10.2307/j.ctvzxxb18.12

DOI: https://doi.org/10.22146/farmaseutik.v18i4.72748